SCHEMBL14907007

SCHEMBL14907007

O=C(N/N=C/c1ccc(Cl)cc1Cl)c1ccc(O)c(O)c1O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CG P48736 2/20 0.58
LMNA P02545 3/20 0.57
NTRK1 P04629 1/20 0.55
MAPT P10636 3/20 0.55
RAB9A P51151 3/20 0.55
KDM4E B2RXH2 3/20 0.55
MEN1 O00255 3/20 0.55
KMT2A Q03164 3/20 0.55
CYP1A2 P05177 2/20 0.55
CYP2C19 P33261 2/20 0.55
NPC1 O15118 2/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
HTT P42858 2/20 0.55
CYP3A4 P08684 1/20 0.55
CYP2D6 P10635 1/20 0.55
CYP2C9 P11712 1/20 0.55
GUSB P08236 1/20 0.54
KDM1A O60341 1/20 0.53
PSMD14 O00487 2/20 0.51
POLB P06746 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14907019 0.90 PIK3CG (0.71) PIK3CGLMNANTRK1MAPTRAB9A
SCHEMBL14907015 0.87 PIK3CG (0.72) PIK3CGLMNANTRK1MAPTRAB9A
SCHEMBL14906899 0.84 MAPT (0.57) PIK3CGLMNAMAPTRAB9AKDM4E
SCHEMBL14907116 0.82 KDM4E (0.60) PIK3CGLMNAMAPTRAB9AKDM4E
SCHEMBL14907021 0.82 PIK3CG (0.56) PIK3CGLMNANTRK1MAPTKDM4E
SCHEMBL14907000 0.82 RAB9A (0.64) LMNAMAPTRAB9AKDM4EMEN1
SCHEMBL14906950 0.81 PIK3CG (0.58) PIK3CGLMNANTRK1MAPTRAB9A
SCHEMBL21145747 0.81 RAB9A (0.58) PIK3CGLMNANTRK1MAPTRAB9A
SCHEMBL21145744 0.81 RAB9A (0.58) PIK3CGLMNANTRK1MAPTRAB9A
SCHEMBL13475427 0.81 RAB9A (0.66) LMNAMAPTRAB9AKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9873661-B2 Small molecule malarial Aldolase-TRAP enhancers and glideosome inhibitors NEW YORK UNIVERSITY (US) 2018-01-23 US disclosed
US-20140275088-A1 SMALL MOLECULE MALARIAL ALDOLASE-TRAP ENHANCERS AND GLIDEOSOME INHIBITORS THE JOHNS HOPKINS UNIVERSITY 2014-09-18 US disclosed
WO-2013063243-A1 SMALL MOLECULE MALARIAL ALDOLASE-TRAP ENHANCERS AND GLIDEOSOME INHIBITORS NEW YORK UNIVERSITY (US) 2013-05-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140275088-A1 SMALL MOLECULE MALARIAL ALDOLASE-TRAP ENHANCERS AND GLIDEOSOME INHIBITORS ALDOA, DERA, TALDO1 PIK3CG 3964/4885LMNA 1944/4885NTRK1 4785/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.